文献速递儿童消化与营养

儿童炎症性肠病

Pediatric Inflammatory Bowel Disease.
PubMed 文献 · Pediatrics · 2023-01-01

儿童炎症性肠病约占总病例的10%,表现为直肠出血或肛周病变时需直接转诊内镜评估。无警示症状时,结合病史与血液及粪便生物标志物可帮助鉴别。治疗目标为生化或内镜缓解而非临床缓解,高危患者可 upfront 使用抗肿瘤坏死因子治疗。

要点

  • 直肠出血或肛周病变是警示症状,需直接转诊内镜评估。
  • 无警示症状时,病史联合血液和粪便生物标志物有助鉴别疑似IBD。
  • 治疗目标为生化或内镜缓解,而非仅临床缓解。

核心结论

  • 儿童IBD的管理需关注生长障碍、青春期延迟、心理及体像等独特挑战,并重视向成人医疗过渡的复发风险。

研究设计与样本

  • 本文为state-of-the-art综述,旨在为普通儿科医生提供儿童IBD的更新,以促进与儿科胃肠专科医生的协作。

主要发现

  • 约10%的IBD病例为儿童起病。
  • 直肠出血或肛周病变的临床表现需直接转诊进行内镜评估。
  • 无警示症状时,患者病史联合血液和粪便生物标志物可帮助区分疑似IBD与其他腹痛或腹泻原因。
  • 对复杂疾病高危患者,可 upfront 使用抗肿瘤坏死因子治疗。
  • 即使达到缓解,许多患者仍持续经历腹痛和疲劳等非特异性症状。

关键数值与推荐

  • 治疗目标为生化或内镜缓解,而非临床缓解,因为腹部症状缓解后肠道炎症常持续存在。

临床怎么用

  • 普通儿科医生应识别警示症状并及时转诊,整合生长、心理及过渡期管理以优化结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inflammatory bowel diseases (IBDs) are chronic, immune-mediated disorders that include Crohn's disease and ulcerative colitis. A pediatric onset of disease occurs in about 10% of all cases. Clinical presentation of IBD with rectal bleeding or perianal disease warrants direct referral for endoscopic evaluation. In the absence of red-flag symptoms, a combination of patient history and blood and fecal biomarkers can help to distinguish suspected IBD from other causes of abdominal pain or diarrhea. The therapeutic management of pediatric IBD has evolved by taking into account predictors of poor outcome, which justifies the upfront use of anti-tumor necrosis factor therapy for patients at high risk for complicated disease. In treating patients with IBD, biochemical or endoscopic remission, rather than clinical remission, is the therapeutic goal because intestinal inflammation often persists despite resolution of abdominal symptoms. Pediatric IBD comes with unique additional challenges, such as growth impairment, pubertal delay, the psychology of adolescence, and development of body image. Even after remission has been achieved, many patients with IBD continue to experience nonspecific symptoms like abdominal pain and fatigue. Transfer to adult care is a well-recognized risk for disease relapse, which highlights patient vulnerability and the need for a transition program that is continued by the adult-oriented IBD team. The general pediatrician is an invaluable link in integrating these challenges in the clinical care of patients with IBD and optimizing their outcomes. This state-of-the-art review aims to provide general pediatricians with an update on pediatric IBD to facilitate interactions with pediatric gastrointestinal specialists.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Bouhuys M, Lexmond WS, van Rheenen PF, et al. Pediatric Inflammatory Bowel Disease. Pediatrics. 2023. PMID: 36545774. doi:10.1542/peds.2022-058037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。